ASH1L and hepatocellular carcinoma: By crossing this HSC‐specific knockout mouse with the hepatocyte‐specific knockout mouse, we revealed that simultaneous depletion of Ash1l in both hepatocytes and HSCs mitigates fibrosis and HCC development.